A critical advance in cancer study is arising with the use of nanobodies to reactivate dysfunctional p53. This vital tumor protector protein is frequently disabled in many kinds of tumors, leading uncontrolled cell https://webookmarks.com/story7623256/nanobodies-reactivate-the-p53-protein-a-new-pathway-for-tumor-treatment